Found: 7
Select item for more details and to access through your institution.
Targeting Proteasomes and the MHC Class I Antigen Presentation Machinery to Treat Cancer, Infections and Age-Related Diseases.
- Published in:
- Cancers, 2023, v. 15, n. 23, p. 5632, doi. 10.3390/cancers15235632
- By:
- Publication type:
- Article
Current and Emerging Strategies to Treat Urothelial Carcinoma.
- Published in:
- Cancers, 2023, v. 15, n. 19, p. 4886, doi. 10.3390/cancers15194886
- By:
- Publication type:
- Article
Targeting Proteasomes in Cancer and Infectious Disease: A Parallel Strategy to Treat Malignancies and Microbes.
- Published in:
- Frontiers in Cellular & Infection Microbiology, 2022, v. 12, p. 1, doi. 10.3389/fcimb.2022.925804
- By:
- Publication type:
- Article
Deciphering mechanisms of immune escape to inform immunotherapeutic strategies in multiple myeloma.
- Published in:
- Journal of Hematology & Oncology, 2022, v. 15, n. 1, p. 1, doi. 10.1186/s13045-022-01234-2
- By:
- Publication type:
- Article
Novel therapies emerging in oncology to target the TGF-β pathway.
- Published in:
- Journal of Hematology & Oncology, 2021, v. 14, n. 1, p. 1, doi. 10.1186/s13045-021-01053-x
- By:
- Publication type:
- Article
Phase I Trial of Lithium and Tretinoin for Treatment of Relapsed and Refractory Non-promyelocytic Acute Myeloid Leukemia.
- Published in:
- Frontiers in Oncology, 2020, p. 1, doi. 10.3389/fonc.2020.00327
- By:
- Publication type:
- Article
The TGFβ type I receptor kinase inhibitor vactosertib in combination with pomalidomide in relapsed/refractory multiple myeloma: a phase 1b trial.
- Published in:
- Nature Communications, 2024, v. 15, n. 1, p. 1, doi. 10.1038/s41467-024-51442-2
- By:
- Publication type:
- Article